Long-Term Study Finds No Link Between Prenatal Paracetamol Use and Autism Risk

A recent scientific investigation has revisited the ongoing debate regarding the safety of paracetamol (also known as Tylenol) use during pregnancy, particularly concerning claims that it may be linked to autism spectrum disorder (ASD) in children.

This extensive study, conducted over nearly twenty years in Hong Kong, concluded that there is no evidence indicating that prenatal exposure to paracetamol raises the likelihood of children developing ASD or attention deficit hyperactivity disorder (ADHD).

The researchers analyzed data from more than 708,020 mother-child pairs, employing a statistical method called "sibling matching." This approach compares siblings within the same family where one was exposed to the medication during pregnancy and the other was not, allowing for a more precise isolation of the drug’s effects while minimizing the influence of shared genetic and environmental factors.

Findings demonstrated that paracetamol use during pregnancy was not associated with an increased risk of either disorder, regardless of dosage or timing of use during pregnancy. No differences were observed between early or late pregnancy exposure.

Why Previous Associations May Not Indicate Causation

This research emerges amid renewed discussion about paracetamol after previous observational studies suggested a possible association with higher autism risk. However, those earlier studies did not establish a clear causal relationship.

International health organizations, including the World Health Organization and regulatory bodies in the United Kingdom, maintain that paracetamol remains a safe option during pregnancy when used according to medical guidelines.

Prior research has indicated that some associations found in traditional studies disappear when more rigorous analytical methods, such as sibling comparisons, are applied. This suggests that familial or genetic factors, rather than the medication itself, may explain these correlations.

Extended Medical Records and Additional Analyses

In this study, investigators also reviewed official medical records spanning many years, with some cases followed for up to 23 years, tracking children's diagnoses over time.

The team conducted supplementary analyses involving mothers who used paracetamol before pregnancy or after childbirth. These analyses revealed similar slight increases in risk, supporting the hypothesis that shared family factors likely underlie the observed associations rather than paracetamol use.

Concluding their study, the researchers emphasized that paracetamol remains an important therapeutic option for managing pain and fever during pregnancy. They cautioned that avoiding its use without medical necessity could result in untreated fever or resorting to alternatives potentially more harmful to the fetus, such as certain anti-inflammatory drugs or opioids.

The study’s results were published in the journal JAMA Internal Medicine.